about
Targeted Polymeric Nanoparticles for Brain Delivery of High Molecular Weight Molecules in Lysosomal Storage DisordersLGI1 microdeletion in autosomal dominant lateral temporal epilepsy.Brain RNA-Seq Profiling of the Mucopolysaccharidosis Type II Mouse Model.Circadian transcriptome analysis in human fibroblasts from Hunter syndrome and impact of iduronate-2-sulfatase treatment.Familial temporal lobe epilepsy with psychic auras associated with a novel LGI1 mutation.FGF signaling deregulation is associated with early developmental skeletal defects in animal models for mucopolysaccharidosis type II (MPSII).Molecular diagnosis of patients affected by mucopolysaccharidosis: a multicenter studyTargeting Brain Disease in MPSII: Preclinical Evaluation of IDS-Loaded PLGA NanoparticlesEarly diagnosis of mucopolysaccharidoses in developing countries: A low cost and easy execution approachMucopolysaccharidosis Type II: One Hundred Years of Research, Diagnosis, and TreatmentComposition and structure of glycosaminoglycans in DBS from 2-3-day-old newborns for the diagnosis of mucopolysaccharidosis
P50
Q28552459-BEBF46A3-3461-474C-A0EF-6A189FC2BA82Q30513770-689E9C3C-3C14-460B-B03C-095B2A209DB1Q33755372-170738CA-B0AE-4AD3-A061-D54A9AAF8C98Q35003652-68D83A60-FA58-4CE7-9D6E-EE2BDB991FA9Q44571958-73DE3C15-B764-418A-9645-A1FD82BBF70DQ52592145-4D0D065B-75F5-4988-8FAD-65AB8A5EF5D6Q64100113-4ACCFB56-F719-4C37-8FFC-59E65778ADD5Q64250020-54B63728-757E-4108-8A25-FEF332AE90B1Q89405120-6D237392-92CD-41A7-98F1-E4FDC2A58AAAQ89762313-742851AF-DF24-4447-B9D1-58199F96663CQ90228841-DE37871B-35BD-4AE7-9F03-5DFA2C77D840
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-0233-1677
@en
name
Laura Rigon
@ast
Laura Rigon
@en
Laura Rigon
@es
Laura Rigon
@nl
type
label
Laura Rigon
@ast
Laura Rigon
@en
Laura Rigon
@es
Laura Rigon
@nl
prefLabel
Laura Rigon
@ast
Laura Rigon
@en
Laura Rigon
@es
Laura Rigon
@nl
P106
P1153
55867456600
P21
P31
P496
0000-0002-0233-1677